| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0444efde206a2f829562761e58b7e1e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2201-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2201-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2063-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2083-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29D11-00365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B13-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-3281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-3218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G77-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-041 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B13-00 |
| filingDate |
2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27320430e70b9e93a630ac02c2f8d282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001c54feb7a5387ab7d5062eb2e2fa1a |
| publicationDate |
2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018284396-A1 |
| titleOfInvention |
Curable composition, cured product thereof, optical member and optical device |
| abstract |
An object of the present invention is to provide a curable composition that can be cured satisfactorily and can form a cured product having a high glass transition temperature as maintained and having high mechanical strength. A curable composition includes a siloxane (A), a cycloaliphatic epoxide (B), and a curing agent (C). The siloxane (A) contains at least two epoxy groups per molecule. The cycloaliphatic epoxide (B) in the curable composition is preferably a compound represented by Formula (I): n n n n n n n n n n wherein X is selected from a single bond and a linkage group. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10988568-B2 |
| priorityDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |